218 related articles for article (PubMed ID: 23116175)
1. No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.
Zou LW; Xu XJ; Liu T; Wang HY; Fan WJ; Wang XH; Zhang ZX; Zhai JX
Genet Test Mol Biomarkers; 2013 Jan; 17(1):78-84. PubMed ID: 23116175
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibility.
Zhang H; Zhang Z; Wu J; Xu Y; Cheng R; Li L
Urol Int; 2013; 91(2):213-9. PubMed ID: 23257985
[TBL] [Abstract][Full Text] [Related]
3. The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis.
Liao YJ; Jiang JR; Jin SQ
Cephalalgia; 2017 May; 37(6):592-598. PubMed ID: 27154995
[TBL] [Abstract][Full Text] [Related]
4. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder.
Rothe C; Koszycki D; Bradwejn J; King N; Deluca V; Tharmalingam S; Macciardi F; Deckert J; Kennedy JL
Neuropsychopharmacology; 2006 Oct; 31(10):2237-42. PubMed ID: 16525418
[TBL] [Abstract][Full Text] [Related]
5. The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
Suzuki M; Mamun MR; Hara K; Ozeki T; Yamada Y; Kadowaki T; Honda H; Yanagihara Y; Ito YM; Kameyama S; Ohta N; Hosoi T; Arai T; Sawabe M; Takeuchi T; Takahashi S; Kitamura T
Eur Urol; 2005 Nov; 48(5):752-9. PubMed ID: 16126332
[TBL] [Abstract][Full Text] [Related]
6. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
[TBL] [Abstract][Full Text] [Related]
7. Association between Val158Met functional polymorphism in the COMT gene and risk of preeclampsia in a Chinese population.
Liang S; Liu X; Fan P; Liu R; Zhang J; He G; Liu Y; Bai H
Arch Med Res; 2012 Feb; 43(2):154-8. PubMed ID: 22475780
[TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis.
Kumar P; Rai V
Metab Brain Dis; 2020 Feb; 35(2):241-251. PubMed ID: 31879835
[TBL] [Abstract][Full Text] [Related]
9. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis.
Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z
J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589
[TBL] [Abstract][Full Text] [Related]
10. The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: a meta-analysis.
Xiao L; Tong M; Jin Y; Huang W; Li Z
Mol Biol Rep; 2013 Feb; 40(2):1835-41. PubMed ID: 23096092
[TBL] [Abstract][Full Text] [Related]
11. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
12. The Association between COMT Val158Met Polymorphism and the Post-Traumatic Stress Disorder Risk: A Meta-Analysis.
Su M; Song Y
Neuropsychobiology; 2022; 81(2):156-170. PubMed ID: 34657037
[TBL] [Abstract][Full Text] [Related]
13. Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.
Lin G; Zhao J; Wu J; Andreevich O R; Zhang WH; Zhang Y; Yu L
Genet Mol Res; 2013 Dec; 12(4):6442-53. PubMed ID: 24390993
[TBL] [Abstract][Full Text] [Related]
14. Association of Val158Met polymorphism in COMT gene with attention-deficit hyperactive disorder: An updated meta-analysis.
Kang P; Luo L; Peng X; Wang Y
Medicine (Baltimore); 2020 Nov; 99(48):e23400. PubMed ID: 33235119
[TBL] [Abstract][Full Text] [Related]
15. Anorexia nervosa and the Val158Met polymorphism of the COMT gene: meta-analysis and new data.
Brandys MK; Slof-Op't Landt MC; van Elburg AA; Ophoff R; Verduijn W; Meulenbelt I; Middeldorp CM; Boomsma DI; van Furth EF; Slagboom E; Kas MJ; Adan RA
Psychiatr Genet; 2012 Jun; 22(3):130-6. PubMed ID: 22366815
[TBL] [Abstract][Full Text] [Related]
16. The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM).
Feng Y; Zhao X; Zhou C; Yang L; Liu Y; Bian C; Gou J; Lin X; Wang Z; Zhao X
Gene; 2013 Oct; 529(2):296-9. PubMed ID: 23939469
[TBL] [Abstract][Full Text] [Related]
17. COMT polymorphisms and anxiety-related personality traits.
Stein MB; Fallin MD; Schork NJ; Gelernter J
Neuropsychopharmacology; 2005 Nov; 30(11):2092-102. PubMed ID: 15956988
[TBL] [Abstract][Full Text] [Related]
18. Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis.
Costas J; Sanjuán J; Ramos-Ríos R; Paz E; Agra S; Ivorra JL; Páramo M; Brenlla J; Arrojo M
J Psychiatr Res; 2011 Jan; 45(1):7-14. PubMed ID: 20488458
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.
de Lau LM; Verbaan D; Marinus J; Heutink P; van Hilten JJ
Mov Disord; 2012 Jan; 27(1):132-5. PubMed ID: 22083803
[TBL] [Abstract][Full Text] [Related]
20. COMT gene val158met polymorphism in patients with dyspeptic symptoms.
Tahara T; Arisawa T; Shibata T; Nakamura M; Wang F; Hirata I
Hepatogastroenterology; 2008; 55(84):979-82. PubMed ID: 18705311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
